MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FOLFIRINOX + NIS793 in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
- Status
- RECRUITING
- Phase
- NA
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2